Trump
the British Department of Health
Chatham House
the European Union
Melinda Gates Foundation
NATO
E.U.
the United Nations General Assembly
the World Health Organization
U.N.
ServiceThe
the Global Times
Communist Party
the Serum Institute of India
Cyrus Poonawalla
Sanofi
Bloomberg News
AstraZeneca
Johns Hopkins University's
Berman Institute of Bioethics
conversation."There
the Associated Press."The
Columbia Business School
Moderna
Johnson & Johnson
the Department of Health and Human Services
the University of Manchester
NBC News Digital
NBC UNIVERSAL
Donald Trump
David Salisbury
Bill
Li Keqiang
Zhang Ming
Emmanuel Macron
Nancy Kass
Frank Lichtenberg
Alex Gorsky
Søren Holm
wait."Alexander Smith
American
European
French
Europe
No matching tags
LONDON
the United States
China
India
America
London
Canada
Japan
Israel
Saudi Arabia
Beijing
E.U
E.U.
Norway
U.S.
battle."Another
U.K.
Boston
New Jersey
race."I
Australia
H1N1
England
South Africa
No matching tags
But the response to it, and the hunt for a vaccine, has been caught up in a tide of nationalism that was already sweeping the world before the virus hit, and may end up delaying distribution of a vaccine to billions of people.This competitive vision outlined in the United States and other vaccine-producing powerhouses such as China and India threatens to undermine the efforts of dozens of countries, which are raising billions of dollars in an attempt to find an effective immunizing shot that they say should be available equally around the world.Some experts and former officials fear that leaders such as President Donald Trump may be pursuing the doctrine of "vaccine nationalism." This is the idea that any government whose scientists win this vaccine "race" — as it's often described — might try to hoard the shots for domestic use."Do you believe that Trump's base will be content with a vaccine strategy that does not 'make America great again'?" asked David Salisbury, a former director of immunization for the British Department of Health who is now an associate fellow at the London think tank Chatham House.
As said here by Alexander Smith